-
WINDSOR, England, May 11, 2017 /PRNewswire/ — Dr Joanne Bedwell-Garner joins management team Macrophage Pharma Limited (‘MPL’) the immuno-oncology development company, announced today that it has appointed Dr Joanne Bedwell-Garner as Development Director. Dr Bedwell-Garner will be responsible for advancing the clinical development of Macrophage Pharma’s lead programme, MPL-5821....
-
ALEXANDRIA, Va. and SANTA CLARA, Calif. and FRIENDSWOOD, Texas, May 9, 2017 /PRNewswire/ — Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and Silicon Valley Bank, the bank of the world’s most innovative companies and their investors, today announced...
-
BASEL and LAUSANNE, Switzerland and HELSINKI, May 9, 2017 /PRNewswire/ — BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round. The round was led by Debiopharm Innovation Fund in conjunction with Tesi, a Finnish venture capital and private...
-
BELLSHILL, Scotland, May 8, 2017 /PRNewswire/ — Lamellar Biomedical, a biotechnology company developing a range of patent–protected medical and pharmaceutical products, based on LAMELLASOME™ technology, has raised £5.75 million in a Series C equity funding round. The financing was led by Invesco Asset Management Limited acting as agent for...
-
SAN DIEGO, April 28, 2017 /PRNewswire/ — Epic Sciences (Epic) announced today that the company has completed a $40 million Series D financing led by Hermed Capital. Altos Capital Partners, Domain Associates, Genomic Health, Pagoda Investment, Reach Tone Limited, RMI Partners, Sabby Capital and VI Ventures also participated in the...
-
CAMBRIDGE, Mass., April 25, 2017 /PRNewswire/ — Aquinnah Pharmaceuticals, a privately held biotechnology company focused on RNA binding proteins for neurodegenerative disease, announced today that two additional pharmaceutical companies, Pfizer Inc. (NYSE: PFE) and AbbVie Inc. (NYSE: ABBV), have invested in Aquinnah’s work to treat ALS (Amyotrophic Lateral Sclerosis),...
WINDSOR, England, May 11, 2017 /PRNewswire/ — Dr Joanne Bedwell-Garner joins management team Macrophage Pharma Limited (‘MPL’) the immuno-oncology development company, announced today that it has appointed Dr Joanne Bedwell-Garner as Development Director. Dr Bedwell-Garner will be responsible for advancing the clinical development of Macrophage Pharma’s lead programme, MPL-5821....
ALEXANDRIA, Va. and SANTA CLARA, Calif. and FRIENDSWOOD, Texas, May 9, 2017 /PRNewswire/ — Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and Silicon Valley Bank, the bank of the world’s most innovative companies and their investors, today announced...
BASEL and LAUSANNE, Switzerland and HELSINKI, May 9, 2017 /PRNewswire/ — BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round. The round was led by Debiopharm Innovation Fund in conjunction with Tesi, a Finnish venture capital and private...